Jump to content

ADH5

From Wikipedia, the free encyclopedia

ADH5
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesADH5, ADH-3, ADHX, FALDH, FDH, GSH-FDH, GSNOR, HEL-S-60p, alcohol dehydrogenase 5 (class III), chi polypeptide, BMFS7, AMEDS
External IDsOMIM: 103710; MGI: 87929; HomoloGene: 68076; GeneCards: ADH5; OMA:ADH5 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_000671

NM_001288578
NM_007410

RefSeq (protein)

NP_000662

NP_001275507
NP_031436

Location (UCSC)Chr 4: 99.07 – 99.09 MbChr 3: 138.15 – 138.16 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Alcohol dehydrogenase class-3 is an enzyme that in humans is encoded by the ADH5 gene.[5][6][7]

This gene encodes glutathione-dependent formaldehyde dehydrogenase or the class III alcohol dehydrogenase chi subunit, which is a member of the alcohol dehydrogenase family. Members of this family metabolize a wide variety of substrates, including ethanol, retinol, other aliphatic alcohols, hydroxysteroids, and lipid peroxidation products. Class III alcohol dehydrogenase is a homodimer composed of 2 chi subunits. It has virtually no activity for ethanol oxidation, but exhibits high activity for oxidation of long-chain primary alcohols and for oxidation of S-hydroxymethyl-glutathione, a spontaneous adduct between formaldehyde and glutathione.

This enzyme is an important component of cellular metabolism for the elimination of formaldehyde, a potent irritant and sensitizing agent that causes lacrymation, rhinitis, pharyngitis, and contact dermatitis.[7]

Clinical significance

[edit]

Mutations of the ADH5 gene and ALDH2 gene cause AMED syndrome, an autosomal recessive digenic multisystem disorder characterized by global developmental delay with impaired intellectual development, short stature, growth impairment and early development of myelodysplastic syndrome and bone marrow failure. The syndrome was first described in 2020.[8]

References

[edit]
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000197894Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000028138Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Hur MW, Edenberg HJ (Dec 1992). "Cloning and characterization of the ADH5 gene encoding human alcohol dehydrogenase 5, formaldehyde dehydrogenase". Gene. 121 (2): 305–11. doi:10.1016/0378-1119(92)90135-C. PMID 1446828.
  6. ^ Adinolfi A, Adinolfi M, Hopkinson DA (May 1984). "Immunological and biochemical characterization of the human alcohol dehydrogenase chi-ADH isozyme". Ann Hum Genet. 48 (Pt 1): 1–10. doi:10.1111/j.1469-1809.1984.tb00828.x. PMID 6424546. S2CID 85113864.
  7. ^ a b "Entrez Gene: ADH5 alcohol dehydrogenase 5 (class III), chi polypeptide".
  8. ^ Kniffin CL (27 November 2023) [Originally published on 13 January 2021]. "AMED SYNDROME, DIGENIC; AMEDS". Online Mendelian Inheritance in Man. Johns Hopkins University. #619151. Retrieved 1 May 2024.

Further reading

[edit]
[edit]